Market Tracker

07/25 4:33am ET

Myriad Genetics Inc (NASDAQ:MYGN)

24.16
Delayed Data
As of Jul 24
 0.00 / 0.00%
Today’s Change
15.15
Today|||52-Week Range
32.54
+44.93%
Year-to-Date
No recent news for Myriad Genetics Inc.

Today’s Trading

Previous close24.16
Today’s open24.18
Day’s range24.01 - 24.45
Volume819,313
Average volume (3 months)1,078,201
Market cap$1.6B
Dividend yield--
Data as of 07/24/2017

Growth & Valuation

Earnings growth (last year)+58.33%
Earnings growth (this year)-37.47%
Earnings growth (next 5 years)-25.51%
Revenue growth (last year)+4.25%
P/E ratio53.7
Price/Sales2.98
Price/Book2.23

Competitors

 Today’s
change
Today’s
% change
AAAPAdvanced Accelerator...+1.28+3.09%
QDELQuidel Corp+0.11+0.29%
--Quidel Corp-0.08-0.25%
IMMUImmunomedics Inc+0.25+2.89%
Data as of 07/24/2017

Financials

Next reporting dateAugust 15, 2017
EPS forecast (this quarter)$0.27
Annual revenue (last year)$753.8M
Annual profit (last year)$125.3M
Net profit margin16.62%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark C. Capone
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts